Consolidated Statements of Operations - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 41,763,047	$ 26,452,942
General and administrative	29,940,188	26,673,440
Loss from operations	(71,703,235)	(53,126,382)
Loss on equity method investment	100,742	10,998
Interest income	(906,150)	(971,480)
Interest expense	3,156,964	2,531,228
Loss on extinguishment of debt		577,659
Change in fair value of promissory notes	2,457,153	3,756,000
Warrant related expenses (Note 9)	37,490,012
Change in fair value of warrant liability	(38,638,042)	(50,919)
Income (loss) before income taxes	(75,363,914)	(58,979,868)
Income tax expense	2,800	2,800
Net income (loss)	$ (75,366,714)	$ (58,982,668)
Per share information:
Net income (loss) per share of common stock, basic (in dollars per share)	$ (4.06)	$ (4.72)
Net loss per share of common stock, diluted (in dollars per share)	$ (4.06)	$ (4.72)
Weighted average shares outstanding, basic (in shares)	18,548,813	12,508,817
Weighted average shares outstanding, diluted (in shares)	18,548,813	12,508,817